查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1827806

2025年全球DNA与基因晶片市场报告

DNA And Gene Chip Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，DNA和基因晶片市场快速扩张，市场规模从2024年的81.9亿美元成长到2025年的92亿美元，复合年增长率为12.2%。预测期内的成长主要得益于基因组学研究的进步、个人化医疗的兴起、人类基因组计划的里程碑、药物研发以及疾病生物标记的识别。

预计未来几年，DNA和基因晶片市场规模将快速成长，到2029年将达到151.3亿美元，复合年增长率为13.3%。预测期内的成长可归因于精准医疗的进步、生物标记发现的不断扩展、个人化医疗的发展、癌症研究的应用以及研究经费的增加。预测期内的主要趋势包括技术进步、产品创新、法律规范和合规性、对罕见疾病的关注以及成本的持续降低。

DNA和基因晶片是一种微晶片，其特征是将微小的DNA探针附着在固体表面上，可以识别测试样本中的DNA，构成DNA双螺旋的一半。如果测试样本中的DNA发生突变，则该DNA将无法正确与晶片上的序列结合。这项技术用于测量基因表现水平，并确定一个人的DNA是否发生突变。

DNA或基因晶片的主要类型包括寡核苷酸DNA（O-DNA）、互补DNA（C-DNA）和其他变异。寡核苷酸DNA由3-20个核苷酸的短单链股或双链DNA或RNA片段组成。与此技术相关的产品包括耗材和仪器，其应用范围涵盖癌症诊断、基因表现、蛋白质体学、基因组学、药物研发和农业基因组学。相关的最终用户产业多种多样，包括学术和政府研究机构、生物技术和製药公司、医院以及诊断中心。

2025年春季，美国关税上调及其引发的贸易摩擦对医疗设备产业产生了重大影响，尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价，製造商面临利润压力。监管挑战使情况更加复杂，因为由于关税而更换供应商通常需要重新认证医疗设备，导致市场准入延迟。为此，企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快研发更具成本效益的材料来降低风险。

本研究报告是商业研究公司（The Business Research Company）新报告系列的一部分，该系列提供DNA和基因晶片市场统计数据，包括全球市场规模、各地区市场份额、各竞争对手的市场份额、详细的DNA和基因晶片细分市场、市场趋势和商业机会，以及您在DNA和基因晶片行业取得成功所需的数据。这份DNA和基因晶片市场研究报告透过对产业现状和未来状况的详细分析，为您提供全面的观点。

未来五年的预测成长率为13.3%，较我们先前对该市场的预测略有下降0.2%。下降主要源自于美国与其他国家之间关税的影响。美国可能会直接感受到这种影响，即对来自瑞典和奥地利等主要地区的寡核苷酸探针和微阵列玻璃基板征收关税，这可能导致基因检测结果延迟，并增加个人化医疗应用的成本。此外，这种影响可能会透过互惠关税以及贸易紧张局势和限制加剧对全球经济和贸易造成的负面影响，在更广泛的范围内显现。

DNA和基因晶片市场正在经历显着增长，这主要得益于对早期癌症检测需求的不断增长。随着癌症成为普遍的健康问题，人们迫切需要能够及时识别的技术。 DNA和基因晶片在测量基因表现、了解遗传图谱以及评估癌细胞中的基因组调控元件方面发挥着至关重要的作用。美国癌症协会估计，2022年美国将新增190万例癌症病例，并有609,360例癌症死亡病例，凸显了DNA和基因晶片在推进早期癌症检测方面将发挥的重要作用。

人们对个人化医疗日益增长的兴趣预计将推动未来 DNA 和基因晶片市场的扩张。个人化医疗是一种新的医疗保健方法，它利用个人的基因图谱来指导疾病预防、诊断和治疗方面的决策。 DNA 和基因晶片在个人化医疗中发挥关键作用，它透过分析个人的基因图谱来识别潜在的疾病风险和治疗方案。例如，美国健康报导机构STAT 报导，2022 年 10 月将有超过 75,000 种基因检测产品和 300 多种个人化药物可供选择。因此，人们对个人化医疗日益增长的兴趣正在推动 DNA 和基因晶片市场的成长。

策略伙伴关係与合作已成为DNA与基因晶片市场的主要趋势。许多该领域的公司正在寻求联盟，以巩固其在DNA和基因晶片市场的地位。例如，2022年6月，总部位于印度的综合系统生物学平台公司Avesthagen Limited与总部位于印度的资讯科技公司Wipro Limited建立了为期四年的策略伙伴关係关係。这项合作关係涉及实施计划，并专注于基因组定序服务。此外，2022年5月，美国分析设备供应商赛默飞世尔科技与卡达基金会（QF）旗下的卡达基因组计画（QGP）合作，利用19个阿拉伯国家的全基因组定序数据，为泛阿拉伯族群开发客製化的Axiom基因型鉴定阵列。该晶片包含80万个基因变异，旨在加强糖尿病、心血管疾病、自闭症和癌症等疾病的基因组研究。此次合作支持卡达改善公民健康、推动全球阿拉伯人民精准医疗的国家愿景，并藉助赛默飞世尔的Axiom晶片技术加速精准医疗倡议。

DNA 和基因晶片市场的关键参与者正在开发创新的基因型鉴定晶片，例如 Axiom YNS_Mol1，以推动食品工业的发展并促进昆虫消费。 Axiom YNS_Mol1 是一种专为昆虫育种而设计的基因型鉴定晶片，特别是针对谷虫。例如，2023 年 6 月，专门从事昆虫生产的法国公司 Ynsect 推出了世界上第一个用于昆虫育种的基因型鉴定晶片 Axiom YNS_Mol1。这款开创性的晶片是与赛默飞世尔科技合作开发的，旨在改变昆虫育种以实现永续的食品和宠物食品生产。此晶片分析遗传性状，增加基因组多样性并改善谷虫的性状，包括生长、繁殖和抗病性。这项创新倡议是 Ynsect 的 YnFABRE计划的一部分，有助于发展昆虫养殖和应对环境挑战的永续解决方案。

2022年12月，总部位于德国、提供DNA和基因晶片的科技公司默克集团与Synplogen签署了一份谅解备忘录。此次伙伴关係旨在推进日本基于病毒载体的基因疗法的开发、生产和测试。此外，默克将在其位于东京的M Lab合作中心为Synplogen的科学家提供实务培训，以促进知识转移和技术援助。 Synplogen株式会社是一家专注于DNA合成的日本公司。

DNA和基因晶片市场包括设备和耗材的销售。该市场的价值是指“出厂价”，即商品製造商或创造者出售给其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接出售给最终客户的价值。该市场中的商品价值还包括商品创造者出售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球DNA与基因晶片：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球DNA与基因晶片市场：成长率分析
  • 全球 DNA 与基因晶片市场表现：规模与成长，2019-2024 年
  • 全球 DNA 与基因晶片市场预测：规模与成长，2024-2029 年，2034 年
  • 全球 DNA 和基因晶片：总目标市场 (TAM)

第六章 市场细分

  • 全球 DNA 和基因晶片市场：按类型、实际和预测，2019-2024 年、2024-2029 年、2034 年
  • 寡核苷酸DNA（o-DNA）
  • 互补DNA（c-DNA）
  • 其他类型
  • 全球 DNA 和基因晶片市场：按应用、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 癌症诊断
  • 基因表现
  • 蛋白质体学
  • 基因组学
  • 药物研发
  • 农业基因组学
  • 其他用途
  • 全球 DNA 和基因晶片市场：按最终用户、实际和预测，2019-2024 年、2024-2029 年、2034 年
  • 学术和政府研究组织
  • 生物技术和製药公司
  • 医院和诊断中心
  • 其他最终用户
  • 全球 DNA 和基因晶片市场：按寡核苷酸 DNA (o-DNA) 细分，类型，实际情况和预测，2019-2024 年，2024-2029 年，2034 年
  • 客製化寡核苷酸晶片
  • 市售寡核苷酸阵列
  • 全球 DNA 和基因晶片市场：按互补 DNA (c-DNA) 细分、类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • cDNA微阵列
  • cDNA表现阵列
  • 全球 DNA 和基因晶片市场：按类型、实际和预测细分，2019-2024 年、2024-2029 年、2034 年
  • 单细胞RNA定序晶片
  • SNP（单核苷酸多态性）晶片
  • 全基因组扩增晶片

第七章 区域和国家分析

  • 全球 DNA 和基因晶片市场：区域表现和预测（2019-2024 年、2024-2029 年、2034 年）
  • 全球 DNA 和基因晶片市场：按国家/地区划分、实际规模和预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章：西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章：俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • DNA与基因晶片市场：竞争格局
  • DNA与基因晶片市场：公司简介
    • PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Macrogen Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Greiner Bio-One International GmbH
  • CapitalBio Corporation
  • Microarrays Inc.
  • bioMerieux SA
  • Applied Microarrays Inc.
  • Biometrix Technology Inc.
  • Oxford Gene Technology IP Limited
  • Bioneer Corporation
  • Eurofins MWG Operon LLC
  • F. Hoffmann-La Roche Ltd
  • QIAGEN NV
  • Bio-Rad Laboratories Inc.
  • BioChain Institute Inc.
  • Cepheid
  • Eppendorf AG

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029 年 DNA 与基因晶片市场：提供新机会的国家
  • 2029 年 DNA 与基因晶片市场：细分市场将带来新机会
  • 2029 年 DNA 与基因晶片市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r22546u

A DNA and gene chip is a microchip featuring microscopic DNA probes attached to a solid surface, capable of identifying DNA from test samples and constituting one half of the DNA double helix. When the test sample of DNA carries a mutation, the DNA fails to bind properly to the sequence on the chip. This technology is employed to measure the expression levels of genes or determine whether a person's DNA exhibits mutations, variations in DNA that can lead to diseases.

The main types of DNA and gene chips include oligonucleotide DNA (O-DNA), complementary DNA (C-DNA), and other variations. Oligonucleotide DNA comprises short single- or double-stranded DNA or RNA fragments with three to twenty nucleotides. Products associated with this technology include consumables and instruments, with applications ranging from cancer diagnostics, gene expression, proteomics, genomics, drug discovery, to agrigenomics. End-user industries involved encompass academic and government research institutes, biotechnology and pharmaceutical companies, hospitals and diagnostics centers, among others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The DNA and gene chips market research report is one of a series of new reports from The Business Research Company that provides DNA and gene chips market statistics, including DNA and gene chips industry global market size, regional shares, competitors with a DNA and gene chips market share, detailed DNA and gene chips market segments, market trends and opportunities, and any further data you may need to thrive in the DNA and gene chips industry. This DNA and gene chips market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The dna and gene chip market size has grown rapidly in recent years. It will grow from $8.19 billion in 2024 to $9.2 billion in 2025 at a compound annual growth rate (CAGR) of 12.2%. The growth in the historic period can be attributed to genomic research advancements, rise of personalized medicine, human genome project milestones, drug discovery and development, disease biomarker identification.

The dna and gene chip market size is expected to see rapid growth in the next few years. It will grow to $15.13 billion in 2029 at a compound annual growth rate (CAGR) of 13.3%. The growth in the forecast period can be attributed to advancements in precision medicine, expansion of biomarker discovery, growth of personalized therapeutics, application in cancer research, increasing research funding. Major trends in the forecast period include technological advancements, product innovations, regulatory framework and compliance, focus on rare diseases, continuous reduction in costs.

The forecast of 13.3% growth over the next five years indicates a slight reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on oligonucleotide probes and microarray glass substrates, sourced from key regions such as Sweden and Austria, which could lead to delayed genetic testing results and increased costs for personalized medicine applications.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The DNA and gene chip market is experiencing substantial growth, primarily fueled by the escalating demand for early cancer detection. Cancer, a pervasive health concern, prompts an urgent need for technologies facilitating timely identification. DNA and gene chips play a pivotal role in measuring gene expression, understanding genetic landscapes, and assessing genomic regulatory elements in cancer cells. Notably, the American Cancer Society estimates approximately 1.9 million new cancer cases and 609,360 deaths in the United States for 2022, emphasizing the critical role of DNA and gene chips in advancing early cancer detection.

The growing emphasis on personalized medicine is anticipated to drive the expansion of the DNA and gene chip market in the future. Personalized medicine is an emerging approach in healthcare that utilizes an individual's genetic profile to inform decisions regarding disease prevention, diagnosis, and treatment. DNA and gene chips play a crucial role in personalized medicine by analyzing a person's genetic profile to identify potential disease risks and treatment options. For example, in October 2022, reports from STAT, a US-based health-focused news organization, indicated that there were over 75,000 genetic testing products and 300 personalized medicines available. Consequently, the heightened focus on personalized medicine is fueling the growth of the DNA and gene chip market.

Strategic partnerships and collaborations are emerging as significant trends in the DNA and gene chip market. Many companies in this field are seeking alliances to enhance their positions within the DNA and gene chip market. For example, in June 2022, Avesthagen Limited, an India-based integrated systems biology platform company, established a four-year strategic partnership with Wipro Limited, an India-based information technology firm. This collaboration involves executing the project titled "Cancer Risk Assessed by NGS profiling of circulating free DNA and RNA for lung cancer," which focuses on genomics sequencing services. Additionally, in May 2022, Thermo Fisher Scientific, a US-based supplier of analytical instruments, partnered with the Qatar Genome Program (QGP), part of the Qatar Foundation (QF), to develop a custom Axiom genotyping array for pan-Arab populations using whole genome sequencing data from 19 Arab countries. This array, featuring 800,000 variants, aims to enhance genomic research on conditions such as diabetes, cardiovascular diseases, autism, and cancer. The collaboration supports Qatar's national vision for improved population health and the advancement of precision medicine for Arab individuals globally, facilitated by Thermo Fisher's Axiom microarray technology, which accelerates precision medicine initiatives.

Key players in the DNA and gene chip market are developing innovative genotyping chips, such as the Axiom YNS_Mol1, to advance the food industry and promote insect consumption. The Axiom YNS_Mol1 is a genotyping chip specifically designed for insect breeding, particularly for the Tenebrio Molitor mealworm. For instance, in June 2023, Ynsect, a France-based company specializing in insect production, introduced the world's first genotyping chip for insect breeding, the Axiom YNS_Mol1. Developed in collaboration with Thermo Fisher Scientific, this pioneering chip aims to transform insect breeding for sustainable food and pet food production. It analyzes genetic traits to enhance genomic diversity and improve characteristics such as growth, reproduction, and disease resistance in Tenebrio Molitor mealworms. This innovative initiative is part of Ynsect's YnFABRE project, contributing to the advancement of entomoculture and sustainable solutions in addressing environmental challenges.

In December 2022, The Merck Group, a German-based science and technology company that offers DNA and gene chips, signed a Memorandum of Understanding (MoU) with Synplogen. This partnership aims to advance the development, manufacturing, and testing of viral vector-based gene therapies in Japan. Additionally, Merck will provide practical training for Synplogen's scientists at its M Lab Collaboration Center in Tokyo, facilitating knowledge transfer and technical assistance. Synplogen Co. Ltd. is a Japan-based company specializing in DNA synthesis.

Major companies operating in the DNA and gene chip market are PerkinElmer Inc., Illumina Inc., Thermo Fisher Scientific Inc., Macrogen Inc., Agilent Technologies Inc., Greiner Bio-One International GmbH, CapitalBio Corporation, Microarrays Inc., bioMerieux SA, Applied Microarrays Inc., Biometrix Technology Inc., Oxford Gene Technology IP Limited, Bioneer Corporation, Eurofins MWG Operon LLC, F. Hoffmann-La Roche Ltd, QIAGEN N.V., Bio-Rad Laboratories Inc., BioChain Institute Inc., Cepheid, Eppendorf AG, Fluidigm Corporation, GE Healthcare, Genisphere LLC, Gyros Protein Technologies AB, Hitachi High-Technologies Corporation, LC Sciences

North America was the largest region in the DNA and gene chip market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the dna and gene chip market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the dna and gene chip market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The DNA and gene chip market consists of sales of instrumentation and consumables. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

DNA And Gene Chip Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on dna and gene chip market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for dna and gene chip ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The dna and gene chip market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Oligonucleotide DNA (o-DNA); Complementary DNA (c-DNA); Other Types
  • 2) By Application: Cancer Diagnostics; Gene Expression; Proteomics; Genomics; Drug Discovery; Agrigenomics; Other Applications
  • 3) By End User: Academic And Government Research Institutes; Biotechnology And Pharmaceutical Companies; Hospitals And Diagnostics Centers; Other End Users
  • Subsegments:
  • 1) By Oligonucleotide DNA (o-DNA): Custom Oligonucleotide Chips; Commercial Oligonucleotide Arrays
  • 2) By Complementary DNA (c-DNA): cDNA Microarrays; cDNA Expression Arrays
  • 3) By Other Types: Single-Cell RNA Sequencing Chips; SNP (Single Nucleotide Polymorphism) Chips; Whole Genome Amplification Chips
  • Companies Mentioned: PerkinElmer Inc.; Illumina Inc.; Thermo Fisher Scientific Inc.; Macrogen Inc.; Agilent Technologies Inc.; Greiner Bio-One International GmbH; CapitalBio Corporation; Microarrays Inc.; bioMerieux SA; Applied Microarrays Inc.; Biometrix Technology Inc.; Oxford Gene Technology IP Limited; Bioneer Corporation; Eurofins MWG Operon LLC; F. Hoffmann-La Roche Ltd; QIAGEN N.V.; Bio-Rad Laboratories Inc.; BioChain Institute Inc.; Cepheid; Eppendorf AG; Fluidigm Corporation; GE Healthcare; Genisphere LLC; Gyros Protein Technologies AB; Hitachi High-Technologies Corporation; LC Sciences
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. DNA And Gene Chip Market Characteristics

3. DNA And Gene Chip Market Trends And Strategies

4. DNA And Gene Chip Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global DNA And Gene Chip Growth Analysis And Strategic Analysis Framework

  • 5.1. Global DNA And Gene Chip PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global DNA And Gene Chip Market Growth Rate Analysis
  • 5.4. Global DNA And Gene Chip Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global DNA And Gene Chip Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global DNA And Gene Chip Total Addressable Market (TAM)

6. DNA And Gene Chip Market Segmentation

  • 6.1. Global DNA And Gene Chip Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oligonucleotide DNA (o-DNA)
  • Complementary DNA (c-DNA)
  • Other Types
  • 6.2. Global DNA And Gene Chip Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cancer Diagnostics
  • Gene Expression
  • Proteomics
  • Genomics
  • Drug Discovery
  • Agrigenomics
  • Other Applications
  • 6.3. Global DNA And Gene Chip Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Academic And Government Research Institutes
  • Biotechnology And Pharmaceutical Companies
  • Hospitals And Diagnostics Centers
  • Other End Users
  • 6.4. Global DNA And Gene Chip Market, Sub-Segmentation Of Oligonucleotide DNA (o-DNA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Custom Oligonucleotide Chips
  • Commercial Oligonucleotide Arrays
  • 6.5. Global DNA And Gene Chip Market, Sub-Segmentation Of Complementary DNA (c-DNA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • cDNA Microarrays
  • cDNA Expression Arrays
  • 6.6. Global DNA And Gene Chip Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single-Cell RNA Sequencing Chips
  • SNP (Single Nucleotide Polymorphism) Chips
  • Whole Genome Amplification Chips

7. DNA And Gene Chip Market Regional And Country Analysis

  • 7.1. Global DNA And Gene Chip Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global DNA And Gene Chip Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific DNA And Gene Chip Market

  • 8.1. Asia-Pacific DNA And Gene Chip Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific DNA And Gene Chip Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific DNA And Gene Chip Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific DNA And Gene Chip Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China DNA And Gene Chip Market

  • 9.1. China DNA And Gene Chip Market Overview
  • 9.2. China DNA And Gene Chip Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China DNA And Gene Chip Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China DNA And Gene Chip Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India DNA And Gene Chip Market

  • 10.1. India DNA And Gene Chip Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India DNA And Gene Chip Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India DNA And Gene Chip Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan DNA And Gene Chip Market

  • 11.1. Japan DNA And Gene Chip Market Overview
  • 11.2. Japan DNA And Gene Chip Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan DNA And Gene Chip Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan DNA And Gene Chip Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia DNA And Gene Chip Market

  • 12.1. Australia DNA And Gene Chip Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia DNA And Gene Chip Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia DNA And Gene Chip Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia DNA And Gene Chip Market

  • 13.1. Indonesia DNA And Gene Chip Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia DNA And Gene Chip Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia DNA And Gene Chip Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea DNA And Gene Chip Market

  • 14.1. South Korea DNA And Gene Chip Market Overview
  • 14.2. South Korea DNA And Gene Chip Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea DNA And Gene Chip Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea DNA And Gene Chip Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe DNA And Gene Chip Market

  • 15.1. Western Europe DNA And Gene Chip Market Overview
  • 15.2. Western Europe DNA And Gene Chip Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe DNA And Gene Chip Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe DNA And Gene Chip Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK DNA And Gene Chip Market

  • 16.1. UK DNA And Gene Chip Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK DNA And Gene Chip Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK DNA And Gene Chip Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany DNA And Gene Chip Market

  • 17.1. Germany DNA And Gene Chip Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany DNA And Gene Chip Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany DNA And Gene Chip Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France DNA And Gene Chip Market

  • 18.1. France DNA And Gene Chip Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France DNA And Gene Chip Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France DNA And Gene Chip Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy DNA And Gene Chip Market

  • 19.1. Italy DNA And Gene Chip Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy DNA And Gene Chip Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy DNA And Gene Chip Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain DNA And Gene Chip Market

  • 20.1. Spain DNA And Gene Chip Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain DNA And Gene Chip Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain DNA And Gene Chip Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe DNA And Gene Chip Market

  • 21.1. Eastern Europe DNA And Gene Chip Market Overview
  • 21.2. Eastern Europe DNA And Gene Chip Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe DNA And Gene Chip Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe DNA And Gene Chip Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia DNA And Gene Chip Market

  • 22.1. Russia DNA And Gene Chip Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia DNA And Gene Chip Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia DNA And Gene Chip Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America DNA And Gene Chip Market

  • 23.1. North America DNA And Gene Chip Market Overview
  • 23.2. North America DNA And Gene Chip Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America DNA And Gene Chip Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America DNA And Gene Chip Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA DNA And Gene Chip Market

  • 24.1. USA DNA And Gene Chip Market Overview
  • 24.2. USA DNA And Gene Chip Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA DNA And Gene Chip Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA DNA And Gene Chip Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada DNA And Gene Chip Market

  • 25.1. Canada DNA And Gene Chip Market Overview
  • 25.2. Canada DNA And Gene Chip Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada DNA And Gene Chip Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada DNA And Gene Chip Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America DNA And Gene Chip Market

  • 26.1. South America DNA And Gene Chip Market Overview
  • 26.2. South America DNA And Gene Chip Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America DNA And Gene Chip Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America DNA And Gene Chip Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil DNA And Gene Chip Market

  • 27.1. Brazil DNA And Gene Chip Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil DNA And Gene Chip Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil DNA And Gene Chip Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East DNA And Gene Chip Market

  • 28.1. Middle East DNA And Gene Chip Market Overview
  • 28.2. Middle East DNA And Gene Chip Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East DNA And Gene Chip Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East DNA And Gene Chip Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa DNA And Gene Chip Market

  • 29.1. Africa DNA And Gene Chip Market Overview
  • 29.2. Africa DNA And Gene Chip Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa DNA And Gene Chip Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa DNA And Gene Chip Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. DNA And Gene Chip Market Competitive Landscape And Company Profiles

  • 30.1. DNA And Gene Chip Market Competitive Landscape
  • 30.2. DNA And Gene Chip Market Company Profiles
    • 30.2.1. PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Macrogen Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

31. DNA And Gene Chip Market Other Major And Innovative Companies

  • 31.1. Greiner Bio-One International GmbH
  • 31.2. CapitalBio Corporation
  • 31.3. Microarrays Inc.
  • 31.4. bioMerieux SA
  • 31.5. Applied Microarrays Inc.
  • 31.6. Biometrix Technology Inc.
  • 31.7. Oxford Gene Technology IP Limited
  • 31.8. Bioneer Corporation
  • 31.9. Eurofins MWG Operon LLC
  • 31.10. F. Hoffmann-La Roche Ltd
  • 31.11. QIAGEN N.V.
  • 31.12. Bio-Rad Laboratories Inc.
  • 31.13. BioChain Institute Inc.
  • 31.14. Cepheid
  • 31.15. Eppendorf AG

32. Global DNA And Gene Chip Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The DNA And Gene Chip Market

34. Recent Developments In The DNA And Gene Chip Market

35. DNA And Gene Chip Market High Potential Countries, Segments and Strategies

  • 35.1 DNA And Gene Chip Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 DNA And Gene Chip Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 DNA And Gene Chip Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer